Nebrija University is a private university based in Madrid, Spain, named after Antonio de Nebrija. It has operated since 1995, and is headquartered in the Nebija-Princesa building in Madrid.

During the past decade, Universidad Nebrija conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universidad Nebrija" are "Post-Acute COVID-19" (2 trials), "Cognitive Dysfunction" (1 trials), "Cognitive Impairment" (1 trials), "Long COVID" (1 trials) and "Post Acute COVID-19 Syndrome" (1 trials). Many other conditions were trialed in "Universidad Nebrija" in a lesser frequency.

Most popular intervention types in "Universidad Nebrija" are "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "CCT Long COVID" (1 trials) and "CogniFit's CCT Post COVID-19" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidad Nebrija" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universidad Nebrija". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universidad Nebrija, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universidad Nebrija, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".